Ginkgo biloba extract EGb 761® for cognitive impairment: clinical data

At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Amos Korczyn, MD, MSc, from Tel Aviv University, Ramat Aviv, Israel, reviews the current clinical evidence of the efficacy and safety of Ginkgo biloba extract EGb 761® for patients with cognitive impairment.

Share this video  
29th May 2016